4.62
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
| Volume | 113 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Terns Pharmaceuticals Inc | TERN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 4.62 | 04:55:02 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.62 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 8 | 113 | - | 1.45 - 13.77 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 04:33:09 | 28 | $ 4.62 | USD |
Period:
Draw Mode:
Terns Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 117.18M | 25.36M | 11.31M | $ 1,000.00k | $ - | -2.35 | -2.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 518.97k | 1.20% |
Terns Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TERN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.25 | 5.50 | 2.25 | 3.90 | 2,876,132 | 2.37 | 105.33% |
| 1 Month | 2.42 | 5.50 | 1.79 | 3.77 | 775,671 | 2.20 | 90.91% |
| 3 Months | 1.54 | 5.50 | 1.51 | 3.20 | 400,373 | 3.08 | 200.0% |
| 6 Months | 3.56 | 5.50 | 1.45 | 2.99 | 232,801 | 1.06 | 29.78% |
| 1 Year | 11.18 | 13.77 | 1.45 | 4.19 | 147,603 | -6.56 | -58.68% |
| 3 Years | 16.95 | 28.36 | 1.45 | 8.94 | 140,536 | -12.33 | -72.74% |
| 5 Years | 16.95 | 28.36 | 1.45 | 8.94 | 140,536 | -12.33 | -72.74% |
Terns Pharmaceuticals Description
| Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. |